Skip to main content
. 2017 Aug 14;16:103. doi: 10.1186/s12933-017-0584-9

Fig. 3.

Fig. 3

Pattern of Framingham mean score and risks for diabetes related complications in the trial with ascorbic acid arm and acetylsalicylic acid arm versus control arm (n = 422). Control Arm (metformin + Placebo) n = 142, Parallel Arm I: metformin + Ascorbic acid 500 mg OD: n = 139, Parallel Arm II: metformin + acetylsalicylic acid 100 mg OD: n = 141, RDiaC: Risk for diabetes related complications, *p < 0.05, **p < 0.01 independent-samples t test: comparison between interventional arms (I & II) versus Control arm, p < 0.01 independent-samples t test: comparison Parallel arm I versus Parallel arm II